MX2010008308A - Tratamiento para trastornos relacionados con los ojos. - Google Patents

Tratamiento para trastornos relacionados con los ojos.

Info

Publication number
MX2010008308A
MX2010008308A MX2010008308A MX2010008308A MX2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A MX 2010008308 A MX2010008308 A MX 2010008308A
Authority
MX
Mexico
Prior art keywords
treatment
ocular
related disorders
macular degeneration
diabetic
Prior art date
Application number
MX2010008308A
Other languages
English (en)
Inventor
Chang Hahn
Timothy A Gillespy
Thomas Oligino
Ramalinga Dharanipragada
Ellen Matzkin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2010008308A publication Critical patent/MX2010008308A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)

Abstract

(Ver fórmula (I)) Se describe un tratamiento para trastornos relacionados con los ojos, tales como la degeneración macular, y preferentemente degeneración macular asociada a la edad, retinopatía diabética, y edema macular diabético, utilizando un compuesto de Fórmula 1.
MX2010008308A 2008-03-10 2009-03-05 Tratamiento para trastornos relacionados con los ojos. MX2010008308A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3507308P 2008-03-10 2008-03-10
PCT/US2009/036119 WO2009114373A1 (en) 2008-03-10 2009-03-05 Treatment for ocular-related disorders

Publications (1)

Publication Number Publication Date
MX2010008308A true MX2010008308A (es) 2010-08-11

Family

ID=40583469

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008308A MX2010008308A (es) 2008-03-10 2009-03-05 Tratamiento para trastornos relacionados con los ojos.

Country Status (22)

Country Link
EP (1) EP2285378A1 (es)
JP (1) JP2011513488A (es)
KR (1) KR20110009084A (es)
CN (1) CN101965188A (es)
AR (1) AR070975A1 (es)
AU (1) AU2009223501A1 (es)
BR (1) BRPI0909659A2 (es)
CA (1) CA2717991A1 (es)
CL (1) CL2009000551A1 (es)
CO (1) CO6290691A2 (es)
CR (1) CR11644A (es)
DO (1) DOP2010000266A (es)
IL (1) IL207906A0 (es)
MA (1) MA32211B1 (es)
MX (1) MX2010008308A (es)
NI (1) NI201000131A (es)
NZ (1) NZ587906A (es)
RU (1) RU2010141560A (es)
SV (1) SV2010003658A (es)
TW (1) TW200950784A (es)
WO (1) WO2009114373A1 (es)
ZA (1) ZA201005337B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074776A1 (es) 2008-12-18 2011-02-09 Sanofi Aventis Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA005212B1 (ru) * 1999-12-24 2004-12-30 Авентис Фарма Лимитед Азаиндолы
AU778417B2 (en) * 2000-02-25 2004-12-02 Merck & Co., Inc. Tyrosine kinase inhibitors
KR20140025610A (ko) * 2005-09-30 2014-03-04 미카나 테라퓨틱스, 인크. 치환된 피라졸 화합물
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.

Also Published As

Publication number Publication date
CR11644A (es) 2010-11-22
EP2285378A1 (en) 2011-02-23
SV2010003658A (es) 2011-01-31
BRPI0909659A2 (pt) 2015-09-22
CN101965188A (zh) 2011-02-02
KR20110009084A (ko) 2011-01-27
AU2009223501A1 (en) 2009-09-17
RU2010141560A (ru) 2012-04-20
JP2011513488A (ja) 2011-04-28
ZA201005337B (en) 2011-04-28
MA32211B1 (fr) 2011-04-01
AR070975A1 (es) 2010-05-19
CA2717991A1 (en) 2009-09-17
NI201000131A (es) 2011-09-29
CO6290691A2 (es) 2011-06-20
IL207906A0 (en) 2010-12-30
WO2009114373A1 (en) 2009-09-17
NZ587906A (en) 2011-12-22
TW200950784A (en) 2009-12-16
DOP2010000266A (es) 2010-09-30
CL2009000551A1 (es) 2009-08-21

Similar Documents

Publication Publication Date Title
MX347226B (es) Tratamiento de enfermedad ocular.
MY175318A (en) Androgen composition for treating an opthalmic condition
EA201590053A1 (ru) Модуляторы пути системы комплемента и их применение
TN2013000275A1 (en) Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
PH12014500281A1 (en) Compounds as tyrosine kinase modulators
GEP201706695B (en) Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases
MX358176B (es) El uso de intensificadores, posiblemente asociados con riboflavina, asi como composiciones oftalmicas correspondientes para reticulacion de la cornea, en el tratamiento de queratocono o de otras alteraciones ectasicas de la córnea.
WO2012080497A3 (en) Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
JO3039B1 (ar) طريقة ومركب لعلاج فرط ضغط العين والجلوكوما
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
MX2009003316A (es) Derivados de pirazina-2-carboxamida como moduladores receptores de cb2.
MX2015007916A (es) Peri-carbinoles.
EA201490721A1 (ru) Лекарственное средство для лечения заболеваний передней камеры глаза, включающее ребамипид и агент, удерживающий слезы
MX348024B (es) Compuestos de adamantilo.
GEP20156315B (en) Oxazoline and isoxazoline derivatives as crac modulators
EA201190337A1 (ru) Способ лечения
WO2009074247A8 (de) Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel
NZ597866A (en) Therapeutic lactams
IN2012DN03846A (es)
WO2007089673A3 (en) Compositions and methods for treatment of ophthalmic diseases and disorders
MX2010008308A (es) Tratamiento para trastornos relacionados con los ojos.
MX2014003883A (es) Inhibidores de monoacilglicerol lipasa para el tratamiento de enfermedades metabolicas y transtornos relacionados.
WO2008124151A3 (en) Use of creatine compounds for the treatment of eye disorders
WO2010046865A3 (en) Ophthalmic administration of a composition including brimonidine as a mist
TW200744627A (en) Methods for the treatment of macular degeneration and related eye conditions

Legal Events

Date Code Title Description
FA Abandonment or withdrawal